A phase I/II study assessing OncoPLEX as a potential part of first-line combination therapy for patients newly diagnosed with Glioblastoma Multiform (GBM)

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 14 Feb 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

09 Feb 2022 According to a POLYPID media release, the pre-Investigational New Drug (IND) meeting with the FDA supporting this study was successful.
04 Jan 2022 According to a PolyPid media release, this trial is expected to initiate by the end of 2022
10 Nov 2021 According to a PolyPid media release, the company intends to conduct a pre-Investigational New Drug (IND) meeting with the U.S. FDA later this month.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com